(1) incorporate health equity into the seasonal 
and pandemic influenza planning and response pro-
grams overseen by such officials; and 
(2) in so doing— 
(A) emphasize the inclusion of all popu-
lations; and 
(B) include strategies to reach commu-
nities of color, communities with lower socio-
economic status, seniors, and individuals with 
disabilities, including addressing barriers to 
vaccinations, therapeutics, and diagnostics in 
the point-of-care and at-home self-testing set-
tings. 
(f) EXPANDING ACCESS TO INFLUENZA TREATMENT 
AND ADOPTING LESSONS LEARNED FROM COVID–19 
FEDERAL RETAIL PHARMACY PROGRAM.— 
(1) REPORT.—Not later than 6 months after 
the date of enactment of this Act, the Secretary of 
Health and Human Services shall submit a report to 
the Congress on lessons learned from the COVID– 
19 Federal Retail Pharmacy Program, including as-
pects of the program that could be applied with re-
spect to multianalyte tests that target COVID–19 as 
well as influenza and other upper respiratory vi-
ruses. 
VerDate Sep 11 2014 
00:04 Oct 05, 2023
Jkt 049200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H5846.IH
H5846
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(2) DEMONSTRATION PROJECT.— 
(A) IN GENERAL.—Not later than one year 
after the date of enactment of this Act, the Sec-
retary of Health and Human Services shall ini-
tiate an influenza test-to-treat demonstration 
project that builds on the test-to-treat model 
employed for COVID–19. 
(B) LENGTH; 
LOCATIONS.—This dem-
onstration project under subparagraph (A) shall 
run for the length of one seasonal influenza 
season and be based in one or more of the fol-
lowing locations: 
(i) Facilities that serve vulnerable 
populations, such as populations who are 
in long-term care facilities, are 65 years of 
age or older, may have other medical con-
ditions, and will be in unavoidable close 
contact with others. 
(ii) Federal health care facilities that 
serve at-risk and vulnerable communities, 
such as Indian Health Service clinics, Fed-
erally qualified health centers (as defined 
in section 1861(aa) of the Social Security 
Act (42 U.S.C. 1395x(aa))), and facilities 
of the Department of Veterans Affairs. 
VerDate Sep 11 2014 
20:51 Oct 11, 2023
Jkt 049200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H5846.IH
H5846
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(iii) Existing COVID–19 test-to-treat 
sites at retail pharmacies, potentially in 
specific geographic areas with historically 
high mortality from influenza. 
(iv) Other appropriate locations iden-
tified by the Secretary of Health and 
Human Services, in consultation with ex-
ternal stakeholder organizations, to test 
the operational feasibility and impact of in-
fluenza test-to-treat programs. 
(3) REPORT.—Not later than six months after 
completion of the demonstration project, the Sec-
retary of Health and Human Services shall— 
(A) prepare a report on the demonstration 
project under paragraph (1), including an eval-
uation of the project’s methods, findings, and 
results; and 
(B) make such report publicly available on 
the website of the Department of Health and 
Human Services. 
(g) CREATING ADMINISTRATION PATHWAYS.—The 
Secretary of Health and Human Services may award 
grants to States to create administration pathways for 
pharmacy personnel to administer influenza vaccines, 
tests, and therapeutics, in order to increase vaccination, 
VerDate Sep 11 2014 
00:04 Oct 05, 2023
Jkt 049200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H5846.IH
H5846
kjohnson on DSK7ZCZBW3PROD with $$_JOB
testing, and relevant treatment as needed for adults and 
children. 
(h) STRATEGIC NATIONAL STOCKPILE.—The Sec-
retary of Health and Human Services shall incorporate 
into the Strategic National Stockpile under section 319F– 
2 of the Public Health Service Act (42 U.S.C. 247d–6b) 
products needed to respond to pandemic influenza, includ-
ing through— 
(1) dynamic management of antivirals; 
(2) vendor-managed inventory of testing equip-
ment and supplies; 
(3) replenishment of aging antivirals, testing 
equipment, supplies, and other products; and 
(4) diversification of stockpiled products. 
(i) MONITORING
AND DISTRIBUTING INFLUENZA 
ANTIVIRAL SUPPLIES.—The Secretary of Health and 
Human Services shall— 
(1) 
monitor 
influenza 
antiviral 
supplies 
throughout the country and publicly report chal-
lenges in availability in any region, State, county, or 
metropolitan area; and 
(2) establish a process, to be used in the case 
of a pandemic or during times when influenza 
antiviral supply availability is challenged, to ensure 
rapid and effective distribution of products to areas 
VerDate Sep 11 2014 
00:04 Oct 05, 2023
Jkt 049200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H5846.IH
H5846
kjohnson on DSK7ZCZBW3PROD with $$_JOB
of urgent need in close coordination with manufac-
turers, distributors, and State and local health offi-
cials. 
(j) PLAN FOR ENSURING ACCESS TO APPROPRIATE 
INFLUENZA
THERAPEUTICS, PREEXPOSURE
PROPHY-
LAXIS, AND DIAGNOSTICS.— 
(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of this Act, the Secretary of 
Health and Human Services shall publish a plan for 
ensuring access to appropriate influenza thera-
peutics, preexposure prophylaxis influenza antibody 
products, and influenza diagnostics, including during 
times when availability is challenged in certain re-
gions or localities, for— 
(A) high-risk patients, such as nursing 
home and pediatric patients; 
(B) high-exposure patients, such as first 
responders and health care workers; and 
(C) low-income individuals, individuals cov-
ered by Medicaid, uninsured individuals, Tribal 
communities, and other underserved popu-
lations. 
(2) COMMUNICATIONS EFFORTS.—The plan re-
quired by paragraph (1) shall include communica-
tions efforts to educate the public about the benefits 
VerDate Sep 11 2014 
00:04 Oct 05, 2023
Jkt 049200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H5846.IH
H5846
kjohnson on DSK7ZCZBW3PROD with $$_JOB